Author

S. K. Oda

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. M. Lande· 1 shared A. Valdez· 1 shared B. C. Curtis· 1 shared B. M. Bates· 1 shared C. H. Spurrell· 1 shared C. P. Saxby· 1 shared J. M. Rosser· 1 shared J. Martinez-Reyes· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. M. Lande

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genome-wide CRISPRa screens nominate modulators of CAR T cell survival within distinct tumor cytokine milieus

B. C. Curtis, C. H. Spurrell, L. Flint, A. M. Lande, M. Leonardi, J. M. Rosser, A. Valdez, N. Murren, T. Chai, M. Fitzgerald, J. Martinez-Reyes, C. P. Saxby, S. K. Oda, M. C. Jensen

This paper develops a CRISPRa-based method to identify genes enhancing CAR T cell survival in different tumor environments.

bioRxiv · Mar 16, 2024 · PreprintImmunology

Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacy

K. G. Anderson, S. K. Oda, B. M. Bates, M. G. Burnett, M. Rodgers Suarez, S. L. Ruskin, P. D. Greenberg

This paper enhances ovarian cancer T cell therapy by engineering T cells to co-opt Fas ligand-mediated death signaling into pro-survival signals, improving persistence and therapeutic efficacy.

bioRxiv · Jul 30, 2021Immunology